Feb 2, 2024
James Calhoun- Amount
- Receipt pending ingestion
- Filed
- Feb 6, 2024
Congress ticker disclosure profile
As of August 1 at 7:12 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference AFRM. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
7
Member filers
4
Disclosed ranges
$73K
Most active member desks
4 buys vs 3 sells
Latest trade Feb 2, 2024
Feb 2, 2024
James CalhounApr 10, 2023
Daniel GoldmanMar 4, 2022
Thomas SuozziFeb 11, 2022
Josh GottheimerDec 28, 2021
Josh GottheimerOct 13, 2021
Thomas SuozziOct 12, 2021
Josh Gottheimer| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Feb 2, 2024 | James Calhoun | Buy | Receipt pending ingestion | Feb 6, 2024 | Receipt pending ingestion |
| Apr 10, 2023 | Daniel Goldman | Buy | $1,001 to $15,000 | May 19, 2023 | Open card |
| Mar 4, 2022 | Thomas Suozzi | Sell | $1,001 to $15,000 | May 20, 2022 | Open card |
| Feb 11, 2022 | Josh Gottheimer | Sell | $1,001 to $15,000 | Mar 18, 2022 | Open card |
| Dec 28, 2021 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jan 10, 2022 | Open card |
| Oct 13, 2021 | Thomas Suozzi | Buy | $15,001 to $50,000 | Nov 5, 2021 | Open card |
| Oct 12, 2021 | Josh Gottheimer | Buy | $1,001 to $15,000 | Nov 15, 2021 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 6 of 7 filed rows include disclosed amount ranges (86%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.